Hepatotoxicity after prophylaxis with a nevirapine-containing antiretroviral regimen.
Stuart
S
Johnson
Juliana
J
Chan
Charles L
CL
Bennett
D019380:Anti-HIV Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D019829:Nevirapine / Q000009:adverse effects*; D016273:Occupational Exposure; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine